(Q77338415)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10207809%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

title

A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10207809%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

main subject

sclerosing cholangitis

1 reference

primary sclerosing cholangitis

inferred from title

1 reference

1 reference

R Hultcrantz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10207809%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

R Olsson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10207809%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A Danielsson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10207809%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

G Järnerot

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10207809%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

L Lööf

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10207809%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

B O Ryden

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10207809%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

B Wahren

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10207809%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

U Broomé

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10207809%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 April 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10207809%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10207809%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10207809%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10207809%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

669-673

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10207809%20AND%20SRC:MED&resulttype=core&format=json

Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980198-6

7 January 2021

Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980198-6

7 January 2021

Cholangiocarcinoma complicating primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980198-6

7 January 2021

Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980198-6

7 January 2021

Liver transplantation for malignant disease. Results in 93 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980198-6

7 January 2021

Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980198-6

7 January 2021

Comparison of preoperative serum CA19-9 levels with results of diagnostic imaging modalities in patients undergoing laparotomy for suspected pancreatic or gallbladder disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980198-6

7 January 2021

CA 19-9 and CA 50 in benign and malignant pancreatic and biliary diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980198-6

7 January 2021

Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980198-6

7 January 2021

Colchicine treatment of primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980198-6

7 January 2021

Ludwig Symposium on biliary disorders--part II. Pathologic features and evolution of primary biliary cirrhosis and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980198-6

7 January 2021

Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980198-6

7 January 2021

Natural history and prognostic variables in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980198-6

7 January 2021

Primary sclerosing cholangitis: refinement and validation of survival models

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980198-6

7 January 2021

Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980198-6

7 January 2021

Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980198-6

7 January 2021

CA 19-9 in non-neoplastic liver diseases. A clinical and laboratory study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980198-6

7 January 2021

Marked increase in serum CA 19-9 level in patients with alcoholic cirrhosis: report of four cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980198-6

7 January 2021

Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980198-6

7 January 2021

The effect of benign and malignant liver disease on the tumour markers CA19-9 and CEA.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980198-6

7 January 2021

CA19-9 does not predict cholangiocarcinoma in patients with primary sclerosing cholangitis undergoing liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980198-6

7 January 2021

The influence of cholestasis on CA 50 and CA 242 in pancreatic cancer and benign biliopancreatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980198-6

7 January 2021

10.1016/S0168-8278(99)80198-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10207809%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference